Association of Laparoscopic Surgery with Improved Perioperative and Survival Outcomes in Patients with Resectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis from Propensity-Score Matched Studies.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
16
01
2023
accepted:
26
03
2023
medline:
7
7
2023
pubmed:
28
4
2023
entrez:
28
4
2023
Statut:
ppublish
Résumé
Recent studies have associated laparoscopic surgery with better overall survival (OS) in patients with hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). The potential benefits of laparoscopic liver resection (LLR) over open liver resection (OLR) have not been demonstrated in patients with intrahepatic cholangiocarcinoma (iCC). A systematic review of the PubMed, EMBASE, and Web of Science databases was performed to search studies comparing OS and perioperative outcome for patients with resectable iCC. Propensity-score matched (PSM) studies published from database inception to May 1, 2022 were eligible. A frequentist, patient-level, one-stage meta-analysis was performed to analyze the differences in OS between LLR and OLR. Second, intraoperative, postoperative, and oncological outcomes were compared between the two approaches by using a random-effects DerSimonian-Laird model. Six PSM studies involving data from 1.042 patients (530 OLR vs. 512 LLR) were included. LLR in patients with resectable iCC was found to significantly decrease the hazard of death (stratified hazard ratio [HR]: 0.795 [95% confidence interval [CI]: 0.638-0.992]) compared with OLR. Moreover, LLR appears to be significantly associated with a decrease in intraoperative bleeding (- 161.47 ml [95% CI - 237.26 to - 85.69 ml]) and transfusion (OR = 0.41 [95% CI 0.26-0.69]), as well as with a shorter hospital stay (- 3.16 days [95% CI - 4.98 to - 1.34]) and a lower rate of major (Clavien-Dindo ≥III) complications (OR = 0.60 [95% CI 0.39-0.93]). This large meta-analysis of PSM studies shows that LLR in patients with resectable iCC is associated with improved perioperative outcomes and, being conservative, yields similar OS outcomes compared with OLR.
Sections du résumé
BACKGROUND
BACKGROUND
Recent studies have associated laparoscopic surgery with better overall survival (OS) in patients with hepatocellular carcinoma (HCC) and colorectal liver metastasis (CRLM). The potential benefits of laparoscopic liver resection (LLR) over open liver resection (OLR) have not been demonstrated in patients with intrahepatic cholangiocarcinoma (iCC).
METHODS
METHODS
A systematic review of the PubMed, EMBASE, and Web of Science databases was performed to search studies comparing OS and perioperative outcome for patients with resectable iCC. Propensity-score matched (PSM) studies published from database inception to May 1, 2022 were eligible. A frequentist, patient-level, one-stage meta-analysis was performed to analyze the differences in OS between LLR and OLR. Second, intraoperative, postoperative, and oncological outcomes were compared between the two approaches by using a random-effects DerSimonian-Laird model.
RESULTS
RESULTS
Six PSM studies involving data from 1.042 patients (530 OLR vs. 512 LLR) were included. LLR in patients with resectable iCC was found to significantly decrease the hazard of death (stratified hazard ratio [HR]: 0.795 [95% confidence interval [CI]: 0.638-0.992]) compared with OLR. Moreover, LLR appears to be significantly associated with a decrease in intraoperative bleeding (- 161.47 ml [95% CI - 237.26 to - 85.69 ml]) and transfusion (OR = 0.41 [95% CI 0.26-0.69]), as well as with a shorter hospital stay (- 3.16 days [95% CI - 4.98 to - 1.34]) and a lower rate of major (Clavien-Dindo ≥III) complications (OR = 0.60 [95% CI 0.39-0.93]).
CONCLUSIONS
CONCLUSIONS
This large meta-analysis of PSM studies shows that LLR in patients with resectable iCC is associated with improved perioperative outcomes and, being conservative, yields similar OS outcomes compared with OLR.
Identifiants
pubmed: 37115372
doi: 10.1245/s10434-023-13498-0
pii: 10.1245/s10434-023-13498-0
pmc: PMC10319676
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4888-4901Informations de copyright
© 2023. The Author(s).
Références
Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol. 2020;17:557–88.
doi: 10.1038/s41575-020-0310-z
Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: Facility type is associated with margin status, use of lymphadenectomy and overall survival. World J Surg. 2019;43:1777–87.
doi: 10.1007/s00268-019-04966-4
pubmed: 30820734
Mazzaferro V, Gorgen A, Roayaie S, et al. Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol. 2020;72:364–77.
doi: 10.1016/j.jhep.2019.11.020
pubmed: 31954498
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Version 1. 2022. NCCN.org.
de Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol. 2011;29:3140–5.
doi: 10.1200/JCO.2011.35.6519
pubmed: 21730269
Liu W-W, Tu J-F, Ying X-H, et al. Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. Bmj Open. 2022;12:e049789.
doi: 10.1136/bmjopen-2021-049789
pubmed: 35414539
pmcid: 9006842
Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20:663–73.
doi: 10.1016/S1470-2045(18)30915-X
pubmed: 30922733
Ciria R, Gomez-Luque I, Ocaña S, et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for hepatocellular carcinoma: Updated Results from the European Guidelines Meeting on Laparoscopic Liver Surgery, Southampton, UK, 2017. Ann Surg Oncol. 2019;26:252–63.
doi: 10.1245/s10434-018-6926-3
pubmed: 30390167
Ciria R, Ocaña S, Gomez-Luque I, et al. A systematic review and meta-analysis comparing the short- and long-term outcomes for laparoscopic and open liver resections for liver metastases from colorectal cancer. Surg Endosc. 2020;34:349–60.
doi: 10.1007/s00464-019-06774-2
pubmed: 30989374
Mavros MN, de Jong M, Dogeas E, et al. Impact of complications on long-term survival after resection of colorectal liver metastases. Brit J Surg. 2013;100:711–8.
doi: 10.1002/bjs.9060
pubmed: 23364914
Fretland ÅA, Dagenborg VJ, Bjørnelv GMW, et al. Laparoscopic versus open resection for colorectal liver metastases. Ann Surg. 2018;267:199–207.
doi: 10.1097/SLA.0000000000002353
pubmed: 28657937
Yamashita S, Sheth RA, Niekamp AS, et al. Comprehensive complication index predicts cancer-specific survival after resection of colorectal metastases independent of RAS mutational status. Ann Surg. 2017;266:1045–54.
doi: 10.1097/SLA.0000000000002018
pubmed: 27735824
Hallet J, Tsang M, Cheng ESW, et al. The impact of perioperative red blood cell transfusions on long-term outcomes after hepatectomy for colorectal liver metastases. Ann Surg Oncol. 2015;22:4038–45.
doi: 10.1245/s10434-015-4477-4
pubmed: 25752895
Kabir T, Tan ZZ, Syn NL, et al. Laparoscopic versus open resection of hepatocellular carcinoma in patients with cirrhosis: meta-analysis. Brit J Surg. 2021;109:21–9.
doi: 10.1093/bjs/znab376
pubmed: 34757385
Syn NL, Kabir T, Koh YX, et al. Survival advantage of laparoscopic versus open resection for colorectal liver metastases: a meta-analysis of individual patient data from randomized trials and propensity-score matched studies. Ann Surg. 2019;272:253–65.
doi: 10.1097/SLA.0000000000003672
Tierney J, Stewart L, Clarke M. Individual participant data. In: Higgins J, Thomas J, Chandler J, et al. (eds). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available at: www.training.cochrane.org/handbook . 2022.
MJ P, JM, PB, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews 2020. MetaArXiv. 14, 2020. https://doi.org/10.31222/osf.io/v7gm2 .
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications. Ann Surg. 2004;240:205–13.
doi: 10.1097/01.sla.0000133083.54934.ae
pubmed: 15273542
pmcid: 1360123
Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 4 April 2022.
Guyot P, Ades A, Ouwens MJ, et al. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. Bmc Med Res Methodol. 2012;12:9.
doi: 10.1186/1471-2288-12-9
pubmed: 22297116
pmcid: 3313891
Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16.
doi: 10.1186/1745-6215-8-16
pubmed: 17555582
pmcid: 1920534
Wei Y, Royston P. Reconstructing time-to-event data from published Kaplan-Meier curves. Stata J. 2017;17:786–802.
doi: 10.1177/1536867X1801700402
pubmed: 29398980
pmcid: 5796634
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–26.
doi: 10.1093/biomet/81.3.515
Lueza B, Rotolo F, Bonastre J, et al. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis. Bmc Med Res Methodol. 2016;16:37.
doi: 10.1186/s12874-016-0137-z
pubmed: 27025706
pmcid: 4812643
Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805.
doi: 10.1177/0962280216669183
pubmed: 27683581
Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Bmc Med Res Methodol. 2014;14:135.
doi: 10.1186/1471-2288-14-135
pubmed: 25524443
pmcid: 4383202
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
doi: 10.1002/sim.1186
pubmed: 12111919
Kang SH, Choi Y, Lee W, et al. Laparoscopic liver resection versus open liver resection for intrahepatic cholangiocarcinoma: 3-year outcomes of a cohort study with propensity score matching. Surg Oncol. 2020;33:63–9.
doi: 10.1016/j.suronc.2020.01.001
pubmed: 32561101
Ratti F, Casadei-Gardini A, Cipriani F, et al. Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes. J Clin Medicine. 2021;10:2828.
doi: 10.3390/jcm10132828
Brustia R, Laurent A, Goumard C, et al. Laparoscopic versus open liver resection for intrahepatic cholangiocarcinoma: Report of an international multicenter cohort study with propensity score matching. Surgery. Epub ahead of print 2021. https://doi.org/10.1016/j.surg.2021.08.015 .
Jinhuan Y, Yi W, Yuanwen Z, et al. Laparoscopic versus open surgery for early-stage intrahepatic cholangiocarcinoma after mastering the learning curve: a multicenter data-based matched study. Frontiers Oncol. 2022;11:742544.
doi: 10.3389/fonc.2021.742544
Zhu Y, Song J, Xu X, et al. Safety and feasibility of laparoscopic liver resection for patients with large or multiple intrahepatic cholangiocarcinomas. Medicine. 2019;98:e18307.
doi: 10.1097/MD.0000000000018307
pubmed: 31804378
pmcid: 6919519
Hobeika C, Cauchy F, Fuks D, et al. Laparoscopic versus open resection of intrahepatic cholangiocarcinoma: nationwide analysis. Brit J Surg. 2021;108:znaa110.
Spolverato G, Yakoob MY, Kim Y, et al. Impact of complications on long-term survival after resection of intrahepatic cholangiocarcinoma. Cancer. 2015;121:2730–9.
doi: 10.1002/cncr.29419
pubmed: 25903409
Fretland AA, Sokolov A, Postriganova N, et al. Inflammatory response after laparoscopic versus open resection of colorectal liver metastases. Medicine. 2015;94:e1786.
doi: 10.1097/MD.0000000000001786
pubmed: 26496309
pmcid: 4620756
Hallet J, Mahar AL, Nathens AB, et al. The impact of perioperative blood transfusions on short-term outcomes following hepatectomy. Hepatobil Surg Nutr. 2017;7:1–10.
doi: 10.21037/hbsn.2017.05.07
Kong M, Chen H, Shan K, et al. Comparison of survival among adults with rectal cancer who have undergone laparoscopic vs open surgery. JAMA Netw Open. 2022;5:e2210861.
doi: 10.1001/jamanetworkopen.2022.10861
pubmed: 35532937
pmcid: 9086842
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
doi: 10.1016/j.cell.2011.02.013
pubmed: 21376230
Ypsilantis P, Lambropoulou M, Anagnostopoulos K, et al. Gut-barrier disruption after laparoscopic versus open major liver resection in the rat. Surgery. 2022;171:973–9.
doi: 10.1016/j.surg.2021.11.002
pubmed: 34876288
Chopra SS, Haacke N, Meisel C, et al. Postoperative immunosuppression after open and laparoscopic liver resection: assessment of cellular immune function and monocytic HLA-DR Expression. Jsls J Soc Laparoendosc Surg. 2013;17:615–21.
doi: 10.4293/108680813X13693422519677
Krall JA, Reinhardt F, Mercury OA, et al. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med. 10. Epub ahead of print 2018. DOI: https://doi.org/10.1126/scitranslmed.aan3464 .
Gómez-Gavara C, Doussot A, Lim C, et al. Impact of intraoperative blood transfusion on short and long term outcomes after curative hepatectomy for intrahepatic cholangiocarcinoma: a propensity score matching analysis by the AFC-IHCC study group. HPB. 2017;19:411–20.
doi: 10.1016/j.hpb.2017.01.001
pubmed: 28122668
Lopez-Aguiar AG, Ethun CG, Pawlik TM, et al. Association of perioperative transfusion with recurrence and survival after resection of distal cholangiocarcinoma: a 10-institution study from the us extrahepatic biliary malignancy consortium. Ann Surg Oncol. 2019;26:1814–23.
doi: 10.1245/s10434-019-07306-x
pubmed: 30877497
pmcid: 10182408
Yoh T, Cauchy F, Roy BL, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study. Surgery. 2019;166:975–82.
doi: 10.1016/j.surg.2019.06.025
pubmed: 31421869
Carlo S, Francesca R, Alessandro C, et al. Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol. Epub ahead of print October 31, 2022. https://doi.org/10.1016/j.jhep.2022.10.021 .
Zhang X-F, Chakedis J, Bagante F, et al. Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg. 2018;105:857–66.
doi: 10.1002/bjs.10827
pubmed: 29656380